1,049 top medical experts on Hepatocellular Carcinoma across 46 countries and 38 U.S. states, including 929 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Hepatocellular Carcinoma: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with epithelial cells indistinguishable from normal hepatocytes to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form giant cells. Several classification schemes have been suggested.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Adenocarcinoma (5,212), Liver Neoplasms (4,219).
- Clinical Trials
: at least 2,107 including 116 Active, 691 Completed, 494 Recruiting
- Synonyms: Hepatoma
- Kudo, MasatoshiDepartment of Gastroenterology and Hepatology, Kindai University, Osaka, Japan.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Chemoembolization, Therapeutic; NiacinamideCategories: Drug Therapy; Therapeutic Use; Therapy; Methods; Pathology; Genetics
- Finn, Richard S Hematology & OncologyGeffen School of Medicine, University of California, Los Angeles, CA, USA. Top HospitalMedical school: University of California, Geffen School of Medicine (MD, 1997)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 67/100Disclosed payments in 2021 from 41 biomedical companies, totalling $57,257.6, including $14,575 from Merck Sharp & Dohme CorporationSubjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Protein Kinase Inhibitors; Antibodies, Monoclonal, HumanizedCategories: Therapeutic Use; Drug Therapy; Therapy; Administration & Dosage; Methods; Analogs & Derivatives
- Llovet, Josep MaríaDivision of Liver Diseases, Department of Medicine, Liver Cancer Program, Tisch Cancer Institute, Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York City, New York, United States of America. Top HospitalSubjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Biomarkers, Tumor; NiacinamideCategories: Genetics; Drug Therapy; Therapeutic Use; Pathology; Therapy; Methods
- Bruix, JordiUnitat dOncologia hepàtica, Liver Unit, Hospital Clínic, Barcelona, Spain.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Liver Cirrhosis; Liver TransplantationCategories: Drug Therapy; Therapeutic Use; Therapy; Surgery; Diagnosis; Pathology
- Zhu, Andrew Xiuxuan Medical OncologyHarvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA. Top HospitalDisclosed payments in 2021 from 22 biomedical companies, totalling $45,896.49, including $8,924.97 from F. Hoffmann-La Roche AGSubjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal, Humanized; Phenylurea CompoundsCategories: Drug Therapy; Therapeutic Use; Radiotherapy; Therapy; Administration & Dosage; Methods
- Cheng, Ann-LiiNational Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Protein Kinase Inhibitors; NiacinamideCategories: Drug Therapy; Therapeutic Use; Pharmacology; Metabolism; Therapy; Administration & Dosage
- Roberts, Lewis Rowland OphthalmologyDivision of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, 200 First Street SW, Rochester, MN, 55905, USA. . Top HospitalSubjects: Carcinoma, Hepatocellular; Liver Neoplasms; Liver Cirrhosis; Hepatitis C, Chronic; Non-alcoholic Fatty Liver Disease; Biomarkers, TumorCategories: Genetics; Metabolism; Epidemiology; Pathology; Therapy; Diagnosis
- El-Serag, Hashem BDepartment of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA. Top HospitalSubjects: Carcinoma, Hepatocellular; Liver Neoplasms; Liver Cirrhosis; Hepatitis C, Chronic; Hepatitis C; Non-alcoholic Fatty Liver DiseaseCategories: Epidemiology; Diagnosis; Complications; Etiology; Virology; Therapy
- Kulik, Laura M GastroenterologyDivision of Hepatology, Department of Medicine, Northwestern University, Chicago, IL, USA. Top HospitalDisclosed payments in 2021 from 17 biomedical companies, totalling $20,776.84, including $8,173.64 from Eisai Inc.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Embolization, Therapeutic; Yttrium Radioisotopes; Chemoembolization, Therapeutic; Liver TransplantationCategories: Therapy; Methods; Therapeutic Use; Pathology; Radiotherapy; Diagnostic Imaging
- Qin, Shu-kuiCancer Center of Nanjing, Jinling Hospital, Nanjing, China.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Antineoplastic Agents; Phenylurea Compounds; Antibodies, Monoclonal, HumanizedCategories: Drug Therapy; Therapeutic Use; Metabolism; Pharmacology; Genetics; Drug Effects
- Marrero, Jorge A Transplant HepatologyDepartment of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Top HospitalSubjects: Carcinoma, Hepatocellular; Liver Neoplasms; Liver Cirrhosis; Early Detection of Cancer; Biomarkers, Tumor; Alpha-FetoproteinsCategories: Diagnosis; Blood; Therapy; Methods; Pathology; Therapeutic Use
- Sangro, BrunoCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas CIBEREHD, Pamplona, Spain.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Embolization, Therapeutic; Yttrium Radioisotopes; Brachytherapy; Chemoembolization, TherapeuticCategories: Therapy; Therapeutic Use; Methods; Drug Therapy; Radiotherapy; Blood
- Sirlin, Claude BDepartment of Radiology, University of California San Diego, San Diego, CA, USA. Top HospitalSubjects: Carcinoma, Hepatocellular; Liver Neoplasms; Magnetic Resonance Imaging; Tomography, X-Ray Computed; Algorithms; Radiology Information SystemsCategories: Diagnostic Imaging; Diagnosis; Methods; Pathology; Standards; Statistics & Numerical Data
- Merle, PhilippeHepatology Unit, Croix-Rousse Hospital, Lyon, France.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Antibodies, Monoclonal, Humanized; Protein Kinase Inhibitors; SorafenibCategories: Drug Therapy; Genetics; Therapeutic Use; Administration & Dosage; Therapy; Metabolism
- Singal, Amit G HepatologyDivision of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.Disclosed payments in 2021 from 22 biomedical companies, totalling $46,702.04, including $12,250 from Bayer HealthCare Pharmaceuticals Inc.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Liver Cirrhosis; Early Detection of Cancer; Alpha-Fetoproteins; Biomarkers, TumorCategories: Diagnosis; Methods; Therapy; Epidemiology; Pathology; Metabolism
- Lim, Ho YeongDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Niacinamide; Antibodies, Monoclonal, HumanizedCategories: Drug Therapy; Therapeutic Use; Administration & Dosage; Genetics; Analogs & Derivatives; Therapy
- Chan, Stephen LamDepartment of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Biomarkers, Tumor; Chemoembolization, Therapeutic; Antibodies, Monoclonal, HumanizedCategories: Drug Therapy; Therapeutic Use; Blood; Therapy; Genetics; Pathology
- Galle, Peter RobertDepartment of Internal Medicine I, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Antineoplastic Agents; Phenylurea Compounds; Chemoembolization, Therapeutic; NiacinamideCategories: Therapy; Therapeutic Use; Drug Therapy; Metabolism; Genetics; Complications
- Han, Kwang-HyubSeverance Hospital, Yonsei University, Seoul, South Korea.Subjects: Carcinoma, Hepatocellular; Liver Neoplasms; Hepatitis B, Chronic; Liver Cirrhosis; Antineoplastic Agents; Chemoembolization, TherapeuticCategories: Therapy; Therapeutic Use; Pathology; Drug Therapy; Complications; Methods
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.